Investigational Site Number : 1560043

Shanghai 200433

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed